BioSurplus Expands to Northern California
* Reuters is not responsible for the content in this press release.
SAN DIEGO, Jan. 15 /PRNewswire/ -- BioSurplus, Inc. today announced its
expansion into Northern California with the addition of Dawn Hocevar and
Suzanne Martinez to its team.
Ms. Hocevar joins the company as Director of Business Development -- Bay
Area. She has over 20 years experience in the life science market, having
served in various senior sales and business development positions for Fisher
Scientific.
Ms. Martinez joins BioSurplus as Manager of Operations -- Bay Area and
will oversee the operations of the company's new facility. She has over
10 years of life science industry experience, serving in product marketing and
account management positions for Molecular Devices Corporation and Hudson
Control Group.
"This expansion is in direct response to our customers and partners, who
have been asking us to open a Bay area operation for quite some time," said
Cinco Plumb, BioSurplus' President and CEO. "We are very excited about the
opportunity to meet our customers' needs with the addition of Dawn and
Suzanne. They have extensive experience with life science companies and
understand scientists' equipment needs."
BioSurplus is scheduled to open a 10,000 square foot showroom and
warehouse facility in the Fremont area in March 2008.
About BioSurplus, Inc.
BioSurplus, Inc. is a leading provider of scientific equipment resale and
asset management services to the life science industry. The company was
founded in 1998 and is headquartered in San Diego.
BioSurplus is the preferred partner for pre-owned laboratory equipment and
management services of the Biotechnology Industry Organization (BIO) through
its Business Solutions(SM) group purchasing program. The benefits offered
through this partnership are available to members of BIO and 31 state/regional
biotechnology associations.
SOURCE BioSurplus, Inc.
Sue Prelozni, MA, Director of Marketing and Business Development of
BioSurplus, Inc., +1-858-550-0800, ext 207, sprelozni@biosurplus.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.


Follow Reuters